Minimizing Patients’ Risk of Adverse Outcomes in NIPT
Lawrence Prensky, MS, LCGC, CCGC, discusses the challenges within NIPT on one of the biggest stages in prenatal health, the CoGEN 2020 World Conference.
Articles and resources
Making NIPT accessible to all women
This webinar aims to address some of the obstacles that have prevented the widescale adoption of NIPT. Issues such as: cost, focus, precision and ease of use will all be examined by our speakers and then reevaluated using PerkinElmer's new Vanadis® NIPT platform. Speakers include Prof. Howard Cuckle (Tel Aviv University, Israel) and Dr Alka Chaubey (PerkinElmer Global Genomic, USA)
Universal access to NIPT: Cost-effective and precise cell-free DNA testing
This PerkinElmer satellite symposium organized at the European Society of Human Genetics (ESHG) Virtual Conference 2020 presents two laboratories’ experience with Vanadis® NIPT, an automated, non-sequencing cell-free DNA testing platform. Speakers include Dr. Alka Chaubey (PerkinElmer Global Genomic, USA) and Prof. Barbara Pasini (University of Turin, Italy).
Clinical validation of a novel automated cell‐free DNA screening assay for trisomies 21, 13, and 18 in maternal plasma
Ericsson et al., Prenatal Diagnosis. 2019
Implementation and Validation of a High-Precision, Non-NGS NIPT Platform
This Genomeweb webinar provides a comprehensive overview of Vanadis® NIPT system, an automated, high-precision non-invasive prenatal testing platform. Speakers: Dr. Glenn Palomaki (Women & Infants Hospital, Rhode Island, USA) and Dr Jérémie Gautier (Cerba Xpert, France).
Imaging single DNA molecules for high precision NIPT
Dahl et al., Scientific Reports, 2018
The new era of cell-free DNA testing
Kypros Nicolaides, Professor at King’s College Hospital, London (UK) and founder of Fetal Medicine Foundation (FMF) presents is perspective on the clinical implementation of cell-free DNA testing, in particular which chromosomal abnormalities should be screened for and the importance of the fetal fraction.
Products may not be licensed in accordance with the laws in all countries, such as the United States, Canada. Please check with your local representative for availability.
Revvity does not endorse or make recommendations with respect to research, medication, or treatments. All information presented is for informational purposes only and is not intended as medical advice. For country specific recommendations please consult your local health care professionals.
